Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Christina Stallings
Washington University, Department: Microbiology/immun/virology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Quretech Bio
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The committees determined Dr. Stallings personal financial relationship with Quretech Bio, related to the above referenced research, creates a financial conflict of interest due to the following reasons:
• Dr. Stallings’s personal financial relationship with Quretech Bio is directly related to the research because the research is evaluating a technology she co-invented, which is being licensed to Quretech Bio
• Dr. Stallings is entitled to future royalties from the sale and distribution of the licensed technology being evaluated in the research
• The primary focus of Quretech Bio is to commercialize the IP being developed and evaluated in the above mentioned research
• The outcomes of the research could directly benefit Quretech Bio
• Since Dr. Stallings owns equity in the company she could directly benefit, should the company’s equity value increase as a result of the study
• Dr. Stallings’s role as described above could directly affect all aspects of the studies
While the committees determined financial conflicts of interest exist, they concluded sufficient mechanisms exist to ensure the objectivity and integrity of the research, based on the following reasons:
• The research is basic in nature and in its early stages.
• Dr. Stallings is uniquely qualified by virtue of her expertise and experience, and the research could not be conducted as effectively without her involvement
• Additionally, a plan has been developed to mitigate her financial conflict of interest
Chemical disarming of drug resistance in Mycobacterium tuberculosis
NARRATIVE Mycobacterium tuberculosis (Mtb) infection causes approximately 9 million new cases of tuberculosis (TB) and 1.5 million TB-related deaths each year. This epidemic is exacerbated by the rise in drug-resistant TB cases, making it clear that we need new strategies to fight these infections. The proposed studies will develop novel antimycobacterials to be used in the treatment of drug-sensitive and drug-resistant TB.
Filed on November 15, 2018.
Tell us what you know about Christina Stallings's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Christina Stallings filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Christina Stallings | Washington University | Conflict of Interest | Fimbrion | $10,000 - $19,999 |
| Christina Stallings | Washington University | Conflict of Interest | Fimbrion | Value cannot be readily determined |
| Christina Stallings | Washington University | Conflict of Interest | Quretech Bio | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.